This blog is related to the various litigations related to patents w.r.t pharma industry.
Monday, May 4, 2009
Ranbaxy Voluntarily Recalls Nitrofurantoin Capsules in the U.S.
Ranbaxy Pharmaceuticals Inc. (RPI) announced today that it is conducting a voluntary recall of all lots of Nitrofurantoin (Monohydrate/Macrocrystals) Capsules, USP 100 mg currently on the market in the U.S.
No comments:
Post a Comment